RAPIDe-1 Phase 2 Top-line Data Dec 8, 2022 8:00 AM EST Click for Webcast Supporting Materials Pharvaris Announces Positive Top-line Phase 2 Data from RAPIDe-1 Study of PHVS416 for the On-Demand Treatment of HAE Attacks 193.1 KB RAPIDe-1 Phase 2 Top-line Data Presentation 2.2 MB
Pharvaris Announces Positive Top-line Phase 2 Data from RAPIDe-1 Study of PHVS416 for the On-Demand Treatment of HAE Attacks 193.1 KB
